Oncology Stock News Bite – G1 Therapeutics (NASDAQ: GTHX) Trades Up on Fourth Quarter and Full Year 2023 Financial Results

February 28, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com) Oncology Stock News Bites – G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today provided a corporate and financial update for the fourth quarter and full year ended December 31, 2023. The stock traded up on today’s news and is currently trading at $3.2278, gaining 34.4917%. “The … Read more

Insurance News: How AI is enabling the future workforce | Insurance Blog

The insurance industry continues to cope with an aging workforce and with the impacts of the Great Resignation. To fill the resource gaps, carriers are increasingly turning to collaborative robots, or cobots, to help train and retain younger workers.  In this Insurance News Analysis, we were delighted to welcome Matt Coughlin, Founder & CEO of … Read more

Renewable Energy Stock News Bite

February 22, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com) Renewable Energy Stock News Bites – Innergex Renewable Energy Inc. (TSX: INE) makes the top TSX gainers list trading at $8.06, up $0.90 (+12.57%). The company announced that it has received approval from the Toronto Stock Exchange (“TSX”) to proceed with its normal course issuer bid on its … Read more

Hydrogen Stock News Bite – Fusion Fuel (NASDAQ: HTOO) Reports Notification of IPCEI Approval from European Commission for 630 MW HEVO-Portugal Project

February 16, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com) Hydrogen Stock News Bites – Fusion Fuel (NASDAQ: HTOO) reports that it has received notification from the European Commission that the Company’s HEVO-Portugal project was among 33 selected for approval under the Important Projects of Common European Interest (“IPCEI”) Hy2Infra program. The €650 million, 630 MW project is … Read more

Insurance News: Cloud connectivity in an evolving risk landscape | Insurance Blog

With all the connectivity that cloud enables, and complex dynamics at play in determining who has the responsibility to process and protect PII, insurers need to work with their ecosystem partners to protect the data of their customers and employees. In this Insurance News Analysis, we were delighted to welcome Aaron Davidson, Global Head of … Read more

Water Stock News – Consortium including Eco Wave Power (NASDAQ: WAVE), Toshiba, Hitachi Energy, and UK Universities Secure £1.5 Million Grant to Develop Wave-Powered Microgrid for Island in Thailand

Tel Aviv, Israel – February 8, 2024 (Investorideas.com Newswire) Eco Wave Power Global (Nasdaq: WAVE) (“Eco Wave Power” or the “Company” or “EWP”), a leading, publicly traded onshore wave energy company, is pleased to announce that it has won a £1.5 million grant (the “Grant”) as part of a consortium led by Toshiba (U.K.) and … Read more

Hydrogen Stock News Bite – Hyzon (NASDAQ: HYZN), And New Way Trucks to Develop Hydrogen Fuel Cell Refuse Truck

February 6, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com) Hydrogen Stock News Bites – Hyzon Motors Inc. (NASDAQ: HYZN), a leading hydrogen fuel cell technology developer and global supplier of zero-emission heavy-duty fuel cell electric vehicles (FCEVs), and privately held New Way Trucks (New Way), today announced a Joint Development Agreement (JDA) to develop a fuel cell … Read more

Insurance News: The next horizon of expansion | Insurance Blog

As insurers look to the next horizon of expansion with an inclusive and diverse approach, there are a number of opportunities influencing scale potential including acquisitions, capital investments, the metaverse and the emergence of insurtech 2.0. In this month’s Insurance News Analysis, Joanne Laffan and I discuss how a pre-scale insurer like Lemonade is planning … Read more

Biopharma Stock Breaking News – BioNTech (Nasdaq: BNTX) and DualityBio Receive FDA Fast Track Designation

MAINZ, Germany and SHANGHAI, China – January 31, 2024 (Investorideas.com Newswire) BioNTech SE (Nasdaq: BNTX”) and Duality Biologics (Suzhou) Co., Ltd. (“DualityBio”) today announced that the U.S. Food and Drug Administration (“FDA”) granted Fast Track designation for BNT325/DB-1305 for the treatment of patients with platinum-resistant ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer … Read more